Insiders · FIXX

FIXX insider transactions

Homology Medicines Inc. (FIXX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for FIXX

• 733d
  Alloway Paul sold $6,488 worth of shares (268 units at $24.21), decreasing direct ownership by 9% to 2,596 units (SEC Form 4)

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 733d
  Michaud Charles Jr sold $1,815 worth of shares (75 units at $24.20), decreasing direct ownership by 7% to 927 units (SEC Form 4)

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 759d
  SEC Form 4 filed by Tzianabos Arthur

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 759d
  SEC Form 4 filed by Manke Isaac

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 760d
  SEC Form 4 filed by Iwicki Mark T

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 760d
  SEC Form 4 filed by Grayzel David S.

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 760d
  SEC Form 4 filed by Xu Diyong

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 760d
  SEC Form 4 filed by Campagna Jason

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 760d
  SEC Form 4 filed by Morrison Jodie Pope

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 760d
  SEC Form 4 filed by Violette Shelia M.

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 760d
  SEC Form 4 filed by Laporte Kathleen

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 760d
  SEC Form 4 filed by Kalowski Lee

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 760d
  SEC Form 4 filed by Thistle Mary

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 760d
  New insider Violette Shelia M. claimed ownership of 36,277 shares (SEC Form 3)

  3 - Q32 Bio Inc. (0001661998) (Issuer)
• 760d
  SEC Form 4 filed by Lundberg Sven Ante

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 760d
  New insider Grayzel David S. claimed ownership of 2,092,106 shares (SEC Form 3)

  3 - Q32 Bio Inc. (0001661998) (Issuer)
• 760d
  SEC Form 3 filed by new insider Manke Isaac

  3 - Q32 Bio Inc. (0001661998) (Issuer)
• 760d
  New insider Xu Diyong claimed ownership of 2,252,987 shares (SEC Form 3)

  3 - Q32 Bio Inc. (0001661998) (Issuer)
• 760d
  SEC Form 3 filed by new insider Morrison Jodie Pope

  3 - Q32 Bio Inc. (0001661998) (Issuer)
• 760d
  New insider Laporte Kathleen claimed ownership of 5,431 shares (SEC Form 3)

  3 - Q32 Bio Inc. (0001661998) (Issuer)
• 760d
  SEC Form 3 filed by new insider Campagna Jason

  3 - Q32 Bio Inc. (0001661998) (Issuer)
• 760d
  SEC Form 3 filed by new insider Kalowski Lee

  3 - Q32 Bio Inc. (0001661998) (Issuer)
• 760d
  New insider Orbimed Advisors Llc claimed ownership of 2,252,987 shares (SEC Form 3)

  3 - Q32 Bio Inc. (0001661998) (Issuer)
• 760d
  SEC Form 3 filed by new insider Iwicki Mark T

  3 - Q32 Bio Inc. (0001661998) (Issuer)
• 760d
  New insider Atlas Venture Fund X, L.P. claimed ownership of 2,092,106 shares (SEC Form 3)

  3 - Q32 Bio Inc. (0001661998) (Issuer)
• 760d
  New insider Lundberg Sven Ante claimed ownership of 1,200 shares (SEC Form 3)

  3 - Q32 Bio Inc. (0001661998) (Issuer)
• 760d
  Alloway Paul converted options into 23,530 shares, increasing direct ownership by 84% to 51,566 units (SEC Form 4)

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 760d
  Michaud Charles Jr converted options into 6,448 shares, increasing direct ownership by 56% to 18,046 units (SEC Form 4)

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 801d
  Tzianabos Arthur sold $7,445 worth of shares (13,037 units at $0.57) and converted options into 33,420 shares, increasing direct ownership by 19% to 128,778 units (SEC Form 4)

  4 - Homology Medicines, Inc. (0001661998) (Issuer)
• 841d
  Alloway Paul sold $4,120 worth of shares (7,280 units at $0.57), decreasing direct ownership by 21% to 28,036 units (SEC Form 4)

  4 - Homology Medicines, Inc. (0001661998) (Issuer)
• 841d
  Michaud Charles Jr sold $975 worth of shares (1,708 units at $0.57), decreasing direct ownership by 13% to 11,598 units (SEC Form 4)

  4 - Homology Medicines, Inc. (0001661998) (Issuer)
• 844d
  Alloway Paul converted options into 18,610 shares, increasing direct ownership by 111% to 35,316 units (SEC Form 4)

  4 - Homology Medicines, Inc. (0001661998) (Issuer)
• 844d
  Michaud Charles Jr converted options into 4,240 shares, increasing direct ownership by 47% to 13,306 units (SEC Form 4)

  4 - Homology Medicines, Inc. (0001661998) (Issuer)
• 867d
  New insider Michaud Charles Jr claimed ownership of 9,066 shares (SEC Form 3) (Amendment)

  3/A - Homology Medicines, Inc. (0001661998) (Issuer)
• 891d
  New insider Michaud Charles Jr claimed ownership of 2,112 shares (SEC Form 3)

  3 - Homology Medicines, Inc. (0001661998) (Issuer)
• 961d
  SEC Form 4: Seymour Albert converted options into 4,620 shares and sold $1,665 worth of shares (1,448 units at $1.15), increasing direct ownership by 2% to 150,874 units

  4 - Homology Medicines, Inc. (0001661998) (Issuer)
• 992d
  SEC Form 4: Jordan Julie converted options into 6,579 shares and sold $2,576 worth of shares (1,853 units at $1.39), increasing direct ownership by 171% to 7,496 units

  4 - Homology Medicines, Inc. (0001661998) (Issuer)
• 996d
  SEC Form 4: Jordan Julie converted options into 350 shares and sold $130 worth of shares (99 units at $1.31), increasing direct ownership by 10% to 2,770 units

  4 - Homology Medicines, Inc. (0001661998) (Issuer)
• 1045d
  SEC Form 4 filed by Gillis Steven

  4 - Homology Medicines, Inc. (0001661998) (Issuer)
• 1045d
  SEC Form 4 filed by Patterson Matthew R

  4 - Homology Medicines, Inc. (0001661998) (Issuer)
• 1045d
  SEC Form 4 filed by Thistle Mary

  4 - Homology Medicines, Inc. (0001661998) (Issuer)
• 1045d
  SEC Form 4 filed by Tzianabos Arthur

  4 - Homology Medicines, Inc. (0001661998) (Issuer)
• 1045d
  SEC Form 4 filed by Poulton Jeffrey V.

  4 - Homology Medicines, Inc. (0001661998) (Issuer)
• 1045d
  SEC Form 4 filed by Reicin Alise

  4 - Homology Medicines, Inc. (0001661998) (Issuer)
• 1137d
  SEC Form 3: New insider Jordan Julie claimed ownership of 2,519 shares

  3 - Homology Medicines, Inc. (0001661998) (Issuer)
• 1154d
  SEC Form 4 filed by Alloway Paul

  4 - Homology Medicines, Inc. (0001661998) (Issuer)
• 1154d
  SEC Form 4 filed by Blum Michael Lee

  4 - Homology Medicines, Inc. (0001661998) (Issuer)
• 1154d
  SEC Form 4 filed by Seymour Albert

  4 - Homology Medicines, Inc. (0001661998) (Issuer)
• 1154d
  SEC Form 4 filed by Smith W Bradford

  4 - Homology Medicines, Inc. (0001661998) (Issuer)
• 1192d
  SEC Form 4 filed by Blum Michael Lee (Amendment)

  4/A - Homology Medicines, Inc. (0001661998) (Issuer)
• 1192d
  SEC Form 3: New insider Blum Michael Lee claimed ownership of 3,280 shares (Amendment)

  3/A - Homology Medicines, Inc. (0001661998) (Issuer)
• 1192d
  SEC Form 4 filed by Alloway Paul (Amendment)

  4/A - Homology Medicines, Inc. (0001661998) (Issuer)
• 1192d
  SEC Form 4 filed by Seymour Albert (Amendment)

  4/A - Homology Medicines, Inc. (0001661998) (Issuer)
• 1201d
  SEC Form 4: Alloway Paul sold $4,296 worth of shares (3,090 units at $1.39) as part of a pre-agreed trading plan, decreasing direct ownership by 13% to 20,103 units (withholding tax)

  4 - Homology Medicines, Inc. (0001661998) (Issuer)
• 1201d
  SEC Form 4: Blum Michael Lee sold $3,412 worth of shares (2,454 units at $1.39) as part of a pre-agreed trading plan, decreasing direct ownership by 15% to 13,538 units to satisfy withholding tax

  4 - Homology Medicines, Inc. (0001661998) (Issuer)
• 1201d
  SEC Form 4: Smith W Bradford sold $5,188 worth of shares (3,729 units at $1.39) as part of a pre-agreed trading plan, decreasing direct ownership by 21% to 14,219 units to cover withholding tax

  4 - Homology Medicines, Inc. (0001661998) (Issuer)
• 1201d
  SEC Form 4: Tzianabos Arthur sold $14,762 worth of shares (10,616 units at $1.39) as part of a pre-agreed trading plan, decreasing direct ownership by 9% to 108,395 units (for withholding tax)

  4 - Homology Medicines, Inc. (0001661998) (Issuer)
• 1201d
  SEC Form 4: Seymour Albert sold $5,033 worth of shares (3,620 units at $1.39) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 143,166 units to cover taxes

  4 - Homology Medicines, Inc. (0001661998) (Issuer)
• 1208d
  SEC Form 4: Blum Michael Lee converted options into 7,590 shares, increasing direct ownership by 90% to 15,992 units

  4 - Homology Medicines, Inc. (0001661998) (Issuer)
• 1208d
  SEC Form 4: Tzianabos Arthur converted options into 33,000 shares, increasing direct ownership by 38% to 119,011 units

  4 - Homology Medicines, Inc. (0001661998) (Issuer)